Cargando…

Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study

BACKGROUND: Chronic kidney disease (CKD)-associated mucocutaneous manifestations significantly impair the quality of life but often remain understudied. They may also vary across regions, socioeconomic and nutritional status, and racial differences. OBJECTIVES: To study the patterns of mucocutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashpa, Rattan S., Mahajan, Vikram K., Kumar, Pankaj, Mehta, Karaninder S., Chauhan, Pushpinder S., Rawat, Ritu, Sharma, Vikas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803936/
https://www.ncbi.nlm.nih.gov/pubmed/29441293
http://dx.doi.org/10.4103/idoj.IDOJ_160_17
_version_ 1783298733512851456
author Rashpa, Rattan S.
Mahajan, Vikram K.
Kumar, Pankaj
Mehta, Karaninder S.
Chauhan, Pushpinder S.
Rawat, Ritu
Sharma, Vikas
author_facet Rashpa, Rattan S.
Mahajan, Vikram K.
Kumar, Pankaj
Mehta, Karaninder S.
Chauhan, Pushpinder S.
Rawat, Ritu
Sharma, Vikas
author_sort Rashpa, Rattan S.
collection PubMed
description BACKGROUND: Chronic kidney disease (CKD)-associated mucocutaneous manifestations significantly impair the quality of life but often remain understudied. They may also vary across regions, socioeconomic and nutritional status, and racial differences. OBJECTIVES: To study the patterns of mucocutaneous disorders and their prevalence in CKD patients irrespective of clinical stage or dialysis status. MATERIALS AND METHODS: 122 (M:F = 77:45) patients aged 21‒85 (Mean ± SD = 57.5 ± 14.0) years having CKD for 3 month to 5 years were studied for mucocutaneous manifestations. Fifty (41%) patients were on hemodialysis for 1‒42 months. Detailed medical history, clinical and mucocutaneous examination, and lab investigations were performed. KOH mounts, skin biopsy, Gram's and Giemsa staining, bacterial or fungal cultures were performed as required. RESULTS: Xerosis in 93 (76.2%), skin pallor in 61 (50%), pruritus in 57 (46.7%), pigmentation in 47 (38.5%), and purpura in 18 (14.8%) patients were the major dermatoses. Bullous lesions and perforating folliculitis occurred in 3 (2.5%) patients each. Major nail abnormalities were pallor (in 35.2%), absent lunula (in 23.8%), nail discoloration (in 18%), and “half-and-half nails” in 16.4% patients, respectively. Hair abnormalities included sparse scalp and body hairs (in 35.2% and 13.1%, respectively) and lusterless hair in 12.3% patients. Coated tongue (in 14.8%), xerostomia (in 12.3%), and macroglossia with teeth indention (in 7.4%) patients were the mucosal manifestations. CONCLUSIONS: Xerosis, pruritus, skin pallor/pigmentary changes, nail pallor, absent lunula, nail discoloration, sparse hairs, coated tongue, xerostomia, macroglossia, and infections were the most common mucocutaneous manifestations in the studied patients irrespective of hemodialysis status. Cold and dry climates might be additional aggravators for xerosis/pruritus. Lifelong follow-up may be needed to reduce the morbidity associated with CKD/hemodialysis specific dermatoses appearing over a period.
format Online
Article
Text
id pubmed-5803936
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-58039362018-02-13 Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study Rashpa, Rattan S. Mahajan, Vikram K. Kumar, Pankaj Mehta, Karaninder S. Chauhan, Pushpinder S. Rawat, Ritu Sharma, Vikas Indian Dermatol Online J Original Article BACKGROUND: Chronic kidney disease (CKD)-associated mucocutaneous manifestations significantly impair the quality of life but often remain understudied. They may also vary across regions, socioeconomic and nutritional status, and racial differences. OBJECTIVES: To study the patterns of mucocutaneous disorders and their prevalence in CKD patients irrespective of clinical stage or dialysis status. MATERIALS AND METHODS: 122 (M:F = 77:45) patients aged 21‒85 (Mean ± SD = 57.5 ± 14.0) years having CKD for 3 month to 5 years were studied for mucocutaneous manifestations. Fifty (41%) patients were on hemodialysis for 1‒42 months. Detailed medical history, clinical and mucocutaneous examination, and lab investigations were performed. KOH mounts, skin biopsy, Gram's and Giemsa staining, bacterial or fungal cultures were performed as required. RESULTS: Xerosis in 93 (76.2%), skin pallor in 61 (50%), pruritus in 57 (46.7%), pigmentation in 47 (38.5%), and purpura in 18 (14.8%) patients were the major dermatoses. Bullous lesions and perforating folliculitis occurred in 3 (2.5%) patients each. Major nail abnormalities were pallor (in 35.2%), absent lunula (in 23.8%), nail discoloration (in 18%), and “half-and-half nails” in 16.4% patients, respectively. Hair abnormalities included sparse scalp and body hairs (in 35.2% and 13.1%, respectively) and lusterless hair in 12.3% patients. Coated tongue (in 14.8%), xerostomia (in 12.3%), and macroglossia with teeth indention (in 7.4%) patients were the mucosal manifestations. CONCLUSIONS: Xerosis, pruritus, skin pallor/pigmentary changes, nail pallor, absent lunula, nail discoloration, sparse hairs, coated tongue, xerostomia, macroglossia, and infections were the most common mucocutaneous manifestations in the studied patients irrespective of hemodialysis status. Cold and dry climates might be additional aggravators for xerosis/pruritus. Lifelong follow-up may be needed to reduce the morbidity associated with CKD/hemodialysis specific dermatoses appearing over a period. Medknow Publications & Media Pvt Ltd 2018 /pmc/articles/PMC5803936/ /pubmed/29441293 http://dx.doi.org/10.4103/idoj.IDOJ_160_17 Text en Copyright: © 2018 Indian Dermatology Online Journal http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Rashpa, Rattan S.
Mahajan, Vikram K.
Kumar, Pankaj
Mehta, Karaninder S.
Chauhan, Pushpinder S.
Rawat, Ritu
Sharma, Vikas
Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study
title Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study
title_full Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study
title_fullStr Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study
title_full_unstemmed Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study
title_short Mucocutaneous Manifestations in Patients with Chronic Kidney Disease: A Cross-sectional Study
title_sort mucocutaneous manifestations in patients with chronic kidney disease: a cross-sectional study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5803936/
https://www.ncbi.nlm.nih.gov/pubmed/29441293
http://dx.doi.org/10.4103/idoj.IDOJ_160_17
work_keys_str_mv AT rashparattans mucocutaneousmanifestationsinpatientswithchronickidneydiseaseacrosssectionalstudy
AT mahajanvikramk mucocutaneousmanifestationsinpatientswithchronickidneydiseaseacrosssectionalstudy
AT kumarpankaj mucocutaneousmanifestationsinpatientswithchronickidneydiseaseacrosssectionalstudy
AT mehtakaraninders mucocutaneousmanifestationsinpatientswithchronickidneydiseaseacrosssectionalstudy
AT chauhanpushpinders mucocutaneousmanifestationsinpatientswithchronickidneydiseaseacrosssectionalstudy
AT rawatritu mucocutaneousmanifestationsinpatientswithchronickidneydiseaseacrosssectionalstudy
AT sharmavikas mucocutaneousmanifestationsinpatientswithchronickidneydiseaseacrosssectionalstudy